Development of Novel 1,3-Disubstituted-2-Thiohydantoin Analogues with Potent Anti-Inflammatory Activity; and Assessments

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Oct 14

PMID 36234810

Authors

Salma M Khirallah

Heba M M Ramadan

Ahmed Shawky

Safa H Qahl

Roua S Baty

Nada Alqadri

Amnah Mohammed Alsuhaibani

Mariusz Jaremko

Abdul-Hamid Emwas

Essa M Saied

Affiliations

Soon will be listed here.

Abstract

Inflammation is the main cause of several autoimmune diseases, including type I diabetes, rheumatoid arthritis, bullous pemphigoid, paraneoplastic pemphigoid, and multiple sclerosis. Currently, there is an urgent demand for the discovery of novel anti-inflammatory drugs with potent activity but also safe for long-term application. Toward this aim, the present study reported the design, synthesis, and characterization of a set of novel 1,3-disubstituted-2-thiohydantoins derivatives. The anti-inflammatory activity of synthesized compounds was assessed against murine leukemia cell line (RAW264.7) by evaluating the cytotoxicity activity and their potency to prevent nitric oxide (NO) production. The results revealed that the synthesized compounds possess a considerable cytotoxic activity together with the ability to reduce the NO production in murine leukemia cell line (RAW264.7). Among synthesized compounds, compound exhibited the most potent cytotoxic activity with IC of 197.68 μg/mL, compared to celecoxib drug (IC value 251.2 μg/mL), and demonstrated a significant ability to diminish the NO production (six-fold reduction). Exploring the mode of action responsible for the anti-inflammatory activity revealed that compound displays a significant and dose-dependent inhibitory effect on the expression of pro-inflammatory cytokines IL-1β. Furthermore, compound demonstrated the ability to significantly reduce the expression of the inflammatory cytokines IL-6 and TNF-α at 50 μg/mL, as compared to Celecoxib. Finally, detailed molecular modelling studies indicated that compound exhibits a substantial binding affinity toward the binding pocket of the cyclooxygenase 2 enzyme. Taken together, our study reveals that 1,3-disubstituted-2-thiohydantoin could be considered as a promising scaffold for the development of potent anti-inflammatory agents.

Citing Articles

Synthesis and antibacterial evaluation of quinoline-sulfonamide hybrid compounds: a promising strategy against bacterial resistance.

Saifi Z, Ali A, Inam A, Azam A, Kamthan M, Abid M RSC Adv. 2025; 15(3):1680-1689.

PMID: 39831044 PMC: 11740869. DOI: 10.1039/d4ra05069j.

Potential Antimicrobial and Cytotoxic Activity of Seed Extract.

Ramalingam S, Bakthavatchalam S, Ramachandran K, Gnanarani Soloman V, Ajmal A, Al-Sadoon M Antibiotics (Basel). 2025; 13(12.

PMID: 39766582 PMC: 11672789. DOI: 10.3390/antibiotics13121193.

Unlocking the pharmacological potential of Brennnesselwurzel (Urtica dioica L.): an in-depth study on multifaceted biological activities.

Elkelish A, Abu-Elsaoud A, Alqahtani A, El-Nablaway M, Al Harthi N, Al Harthi N BMC Complement Med Ther. 2024; 24(1):413.

PMID: 39696148 PMC: 11653956. DOI: 10.1186/s12906-024-04709-6.

Novel Insights into the Antimicrobial and Antibiofilm Activity of Pyrroloquinoline Quinone (PQQ); , , and Shotgun Proteomic Studies.

Labib M, Alqahtani A, Abo Nahas H, Aldossari R, Almiman B, Ayman Alnumaani S Biomolecules. 2024; 14(8).

PMID: 39199405 PMC: 11352295. DOI: 10.3390/biom14081018.

anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety.

Binjawhar D, Al-Salmi F, Ali Alghamdi M, Abu Ali O, Fayad E, Rizzk Y Future Med Chem. 2024; 16(16):1665-1684.

PMID: 38949859 PMC: 11370905. DOI: 10.1080/17568919.2024.2366694.

References

Khalifa S, Shedid E, Saied E, Jassbi A, Jamebozorgi F, Rateb M . Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications. Mar Drugs. 2021; 19(5). PMC: 8146687. DOI: 10.3390/md19050241. View

Mohamed D, Alaa El-Din Aly El-Waseef D, Nabih E, El-Kharashi O, Abd El-Kareem H, Abo Nahas H . Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico Study. Pharmaceutics. 2022; 14(3). PMC: 8948796. DOI: 10.3390/pharmaceutics14030529. View

Elhady H, El-Sayed R, Al-Nathali H . Design, synthesis and evaluation of anticancer activity of novel 2-thioxoimidazolidin-4-one derivatives bearing pyrazole, triazole and benzoxazole moieties. Chem Cent J. 2018; 12(1):51. PMC: 5940965. DOI: 10.1186/s13065-018-0418-1. View

Mohamed D, Ezzat S, Elayat W, El-Kharashi O, Abd El-Kareem H, Abo Nahas H . Hepatoprotective Role of Carvedilol against Ischemic Hepatitis Associated with Acute Heart Failure via Targeting miRNA-17 and Mitochondrial Dynamics-Related Proteins: An In Vivo and In Silico Study. Pharmaceuticals (Basel). 2022; 15(7). PMC: 9319470. DOI: 10.3390/ph15070832. View

Vigil S, de Liz R, Medeiros Y, Frode T . Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch. Transpl Immunol. 2008; 19(1):25-9. DOI: 10.1016/j.trim.2008.01.003. View

Haslak Z, Agopcan Cinar S, Sarigul Ozbek S, Monard G, Dogan I, Aviyente V . Elucidation of the atroposelectivity in the synthesis of axially chiral thiohydantoin derivatives. Org Biomol Chem. 2020; 18(12):2233-2241. DOI: 10.1039/c9ob02556a. View

Gaber A, Refat M, Belal A, El-Deen I, Hassan N, Zakaria R . New Mononuclear and Binuclear Cu(II), Co(II), Ni(II), and Zn(II) Thiosemicarbazone Complexes with Potential Biological Activity: Antimicrobial and Molecular Docking Study. Molecules. 2021; 26(8). PMC: 8071257. DOI: 10.3390/molecules26082288. View

Zarghi A, Arfaei S . Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships. Iran J Pharm Res. 2013; 10(4):655-83. PMC: 3813081. View

Saied E, Banhart S, Burkle S, Heuer D, Arenz C . A series of ceramide analogs modified at the 1-position with potent activity against the intracellular growth of Chlamydia trachomatis. Future Med Chem. 2015; 7(15):1971-80. DOI: 10.4155/fmc.15.126. View

10.

Viegas-Junior C, Danuello A, da Silva Bolzani V, Barreiro E, Fraga C . Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem. 2007; 14(17):1829-52. DOI: 10.2174/092986707781058805. View

11.

Buchynskyy A, Gillespie J, Herbst Z, Ranade R, Buckner F, Gelb M . 1-Benzyl-3-aryl-2-thiohydantoin Derivatives as New Anti- Agents: SAR and in Vivo Efficacy. ACS Med Chem Lett. 2017; 8(8):886-891. PMC: 5554913. DOI: 10.1021/acsmedchemlett.7b00230. View

12.

Yu W, Guo Z, Orth P, Madison V, Chen L, Dai C . Discovery and SAR of hydantoin TACE inhibitors. Bioorg Med Chem Lett. 2010; 20(6):1877-80. DOI: 10.1016/j.bmcl.2010.01.148. View

13.

Torres P, Sodero A, Jofily P, Silva-Jr F . Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019; 20(18). PMC: 6769580. DOI: 10.3390/ijms20184574. View

14.

Saied E, El-Maradny Y, Osman A, Darwish A, Abo Nahas H, Niedbala G . A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19. Pharmaceutics. 2021; 13(11). PMC: 8624722. DOI: 10.3390/pharmaceutics13111759. View

15.

Shiff S, Shivaprasad P, Santini D . Cyclooxygenase inhibitors: drugs for cancer prevention. Curr Opin Pharmacol. 2003; 3(4):352-61. DOI: 10.1016/s1471-4892(03)00087-0. View

16.

Inglis A, Duncan M, Adams P, Tseng A . Formation of proline thiohydantoin with ammonium thiocyanate: progress towards a viable C-terminal amino-acid-sequencing procedure. J Biochem Biophys Methods. 1992; 25(2-3):163-71. DOI: 10.1016/0165-022x(92)90008-x. View

17.

Wang Z, Sheikh S, Zhang Y . A simple synthesis of 2-thiohydantoins. Molecules. 2007; 11(10):739-50. PMC: 6148508. DOI: 10.3390/11100739. View

18.

Gaber A, Alsanie W, Kumar D, Refat M, Saied E . Novel Papaverine Metal Complexes with Potential Anticancer Activities. Molecules. 2020; 25(22). PMC: 7699950. DOI: 10.3390/molecules25225447. View

19.

Kawaguchi H, Pilbeam C, Gronowicz G, Abreu C, Fletcher B, Herschman H . Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest. 1995; 96(2):923-30. PMC: 185280. DOI: 10.1172/JCI118140. View

20.

Maier J, Hla T, Maciag T . Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem. 1990; 265(19):10805-8. View